BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3699864)

  • 1. Humoral immune response in women using intrauterine contraceptive device.
    Chandra M; Aggarwal S; Sachdeva S; Nayar M; Nayar VL
    Indian J Med Res; 1986 Jan; 83():13-8. PubMed ID: 3699864
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of immunoglobulins in the serum and uterine fluid of women using an intrauterine contraceptive device.
    Chandra RK; Malkani PK; Bhasin K
    J Reprod Fertil; 1974 Mar; 37(1):1-6. PubMed ID: 4816944
    [No Abstract]   [Full Text] [Related]  

  • 4. Immuno and histochemical study of endometrium in women using copper IUCD.
    Mousa MA; El-mekkawi TM; Abdel Aziz AA; El-saharty MF
    Popul Sci; 1985; 6():41-50. PubMed ID: 12349093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of immunoglobulins and complement components in women using an intra-uterine contraceptive device (IUCD).
    Sandvei R; Matre R
    Acta Obstet Gynecol Scand; 1987; 66(4):297-9. PubMed ID: 3425227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum immunoglobulin levels in women fitted with a copper T intrauterine contraceptive device (author's transl)].
    Tatra G; Beck A; Prunner Ch; Breitenecker G
    Wien Klin Wochenschr; 1975 Oct; 87(20):681-3. PubMed ID: 1220268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive protein and immunoglobulin levels in women using intrauterine devices.
    Shaarawy M; Naguib YA; El Safory LS; Abdel Kader MM
    Int J Gynaecol Obstet; 1981 Apr; 19(2):125-31. PubMed ID: 6119243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin levels in the serum and cervical mucus of tailed copper IUD users.
    Eissa MK; Sparks RA; Newton JR
    Contraception; 1985 Jul; 32(1):87-95. PubMed ID: 4053606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin levels in women using intrauterine contraceptive devices.
    Shulman G; Polakow ES; Bauer HD
    J Obstet Gynaecol Br Commonw; 1974 Feb; 81(2):155-9. PubMed ID: 4205805
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulins and C-reactive protein in patients using intrauterine contraceptive devices.
    Mountrose UE; Whitehouse WL; Slater L
    Br J Obstet Gynaecol; 1975 Dec; 82(12):992-4. PubMed ID: 1203216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological characteristics of incrustates of intrauterine contraceptive devices.
    Patai K; Berényi M; Asztalos M
    Acta Morphol Hung; 1986; 34(1-2):3-10. PubMed ID: 3105257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial picture at removal of Copper T devices.
    Wahab SA; Askalani AH; Al Agizi H; Al Senity AF; Saleh A; Said I; Wafik AH; Sakr E
    Popul Sci; 1985; 6():51-61. PubMed ID: 12349094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine contraceptive device and increased serum immunoglobulin levels.
    Gump DW; Mead PB; Horton EL; Lamborn KR; Forsyth BR
    Obstet Gynecol; 1973 Feb; 41(2):259-64. PubMed ID: 4684213
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of histamine release - a possible mechanism of action of intrauterine contraceptive device.
    Achari K; Achari G; Kishore K
    J Obstet Gynaecol India; 1973; 23(4):463-7. PubMed ID: 12307064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tubal infertility in relation to the use of an intrauterine device.
    Daling JR; Weiss NS; Metch BJ; Chow WH; Soderstrom RM; Moore DE; Spadoni LR; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):937-41. PubMed ID: 3974683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IUD update: what family planners should know.
    Netw Res Triangle Park N C; 1987; 8(2):1-3. PubMed ID: 12268657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.